6 completed, 4 terminated, 2 withdrawn. 12 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 6, Terminated 4, Withdrawn 2 |
| Phase 1 | 3 | Completed 2, Terminated 1 |
Follow Dexamethasone sodium phosphate: new trials by email Literature Review of Dexamethasone sodium phosphate trials Research Report on Dexamethasone sodium phosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sterile Amniotic Fluid Filtrate Epidural Injection. Amniotic Fluid Allograft, Dexamethasone sodium phosphate - Lumbar Spinal Stenosis | Phase 1 / Phase 2 | Completed | University of Utah | 58 | 2021-06-16 | 2026-09-25 |
| A Phase 2, Open Label, Pharmacokinetic (PK) Study of TLC599 in Subjects With Osteoarthritis of the Knee TLC599, DSP - Osteoarthritis of the Knee | Phase 2 | Completed | Taiwan Liposome Company | 102 | 2019-01-21 | 2024-10-23 |
| Iontophoresis With Dexamethasone and Physical Therapy to Treat Apophysitis of the Knee in Pediatrics Dexamethasone Sodium Phosphate, Iontophoresis, Physical Therapy - Apophysitis; Juvenile | Phase 2 | Terminated | Children's Health System, Inc. | 45 | 2018-11-05 | 2024-03-06 |
| High Dose Oral Steroids in Sudden Sensorineural Hearing Loss Dexamethasone, Prednisone - Sudden Sensorineural Hearing Loss (SSNHL) | Phase 2 | Withdrawn | University of Colorado, Denver | 2017-08-30 | 2024-10-15 | |
| A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL Decitabine, Vorinostat, Vincristine - Acute Lymphoblastic Leukemia, Precursor B-Cell Lymphoblastic Leukemia | Phase 1 / Phase 2 | Terminated | Therapeutic Advances in Childhood Leukemia Consortium | 23 | 2011-12-01 | 2020-10-27 |
| SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma SOM230, Bortezomib, Dexamethasone - Multiple Myeloma in Relapse, Multiple Myeloma | Phase 2 | Withdrawn | University of Pittsburgh | 2011-12-01 | 2016-02-12 | |
| Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies 12-O-tetradecanoylphorbol-13-acetate, Dexamethasone, Choline magnesium trisalicylate - Leukemia | Phase 2 | Terminated | Rutgers, The State University of New Jersey | 1 | 2011-03-01 | 2015-11-04 |
| Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients Dexamethasone - Nervous System Disorder, Genetic Syndrome | Phase 2 | Completed | Quince Therapeutics S.p.A. | 22 | 2011-02-01 | 2024-10-10 |
| Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS) Dexamethasone sodium phosphate - Diabetes, Macular Edema | Phase 2 | Completed | University Health Network, Toronto | 48 | 2010-01-01 | 2011-01-11 |
| MTD, Safety, and Efficacy of Pomalidomide (CC-4047) Alone or With Low-dose Dexamethasone in Patients With Relapsed and Refractory Multiple Myeloma Pomalidomide, Dexamethasone, Aspirin - Multiple Myeloma | Phase 1 / Phase 2 | Completed | Celgene Corporation | 259 | 2008-06-01 | 2016-04-27 |
| Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease bortezomib, dexamethasone, melphalan - Primary Systemic Amyloidosis, Light Chain Deposition Disease | Phase 2 | Completed | Barbara Ann Karmanos Cancer Institute | 35 | 2007-09-01 | 2023-12-22 |
| Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma Rituximab, Cytarabine, Dexamethasone - Lymphoma | Phase 2 | Terminated | Eastern Cooperative Oncology Group | 26 | 2007-08-23 | 2023-07-03 |
Leukemia (2) · Multiple Myeloma (2) · Diabetes Mellitus (1) · Genetic Diseases, Inborn (1) · Hearing Loss, Sudden (1) · Immunoglobulin Light-chain Amyloidosis (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1) · Macular Edema (1) · Nervous System Diseases (1) · Osteoarthritis, Knee (1) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Pseudophakia (1)
Barbara Ann Karmanos Cancer Institute (1) · Celgene Corporation (1) · Children's Health System, Inc. (1) · Eastern Cooperative Oncology Group (1) · Quince Therapeutics S.p.A. (1) · Rutgers, The State University of New Jersey (1) · Taiwan Liposome Company (1) · Therapeutic Advances in Childhood Leukemia Consortium (1) · University Health Network, Toronto (1) · University of Colorado, Denver (1) · University of Pittsburgh (1) · University of Utah (1)
United States (10) · Canada (2) · Australia (1) · Italy (1) · Taiwan (1)
Dana Reesman, PT, DPT (1) · Deborah T. Blumenthal, MD (1) · Jeffrey A. Zonder, MD (1) · Lars A Sternas, MD (1) · Lode J. Swinnen, MD (1) · Luciana Chessa, MD (1) · Michael Burke, MD (1) · Michael H Brent, MD, FRCSC (1) · Roger Strair, MD, PhD (1) · Stephen P Cass, MD (1) · Terry Tai, MD (1) · Zachary L McCormick, MD (1)
PMID 23233571, PMID 23243282, PMID 24421329, PMID 27267105, PMID 29416652, PMID 31969338, PMID 41915069
P30CA022453 (1), P30CA068485 (1), P30CA072720 (1)